{"id":"W2600545212","doi":"10.1200/jco.2014.32.15_suppl.7030","title":"First results of a phase 2 study using a 10-day subcutaneous (SC) regimen of the novel hypomethylating agent (HMA) SGI-110 for the treatment of relapsed/refractory acute myeloid leukemia (r/r AML).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Regimen; Clinical endpoint; Internal medicine; Neutropenia; Refractory (planetary science); Phases of clinical research; Gastroenterology; Surgery; Decitabine; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002319209,0.001441941,0.001564591,0.0003590286,0.0004144052,0.0007148219,0.0007388442,0.001284783,0.002613623],"category_scores_gemma":[0.001347425,0.0004885554,0.001076104,0.0002772839,0.0007284679,0.0006307191,0.0002755906,0.002944389,0.00074967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005337552,"about_ca_system_score_gemma":0.001154301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007739455,"about_ca_topic_score_gemma":0.0018338,"domain_scores_codex":[0.9994173,0.0003126947,0.00003300269,0.00007229132,0.00007214723,0.00009250805],"domain_scores_gemma":[0.9988981,0.0002606577,0.0001766574,0.0001047649,0.00009833946,0.0004613178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4152507,0.2375588,0.01686562,0.001100982,0.00245666,0.001343022,0.0009060069,0.004392471,0.1625516,0.0004013725,0.01190945,0.1452634],"study_design_scores_gemma":[0.230877,0.7284897,0.02227027,0.00003606563,0.0006750142,0.0006475524,0.00005981578,0.001343847,0.01120078,0.0001782798,0.004181813,0.00003970804],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869724,0.001584776,0.001791127,0.0005587921,0.000147233,0.004511786,0.00199867,0.0001593776,0.002275843],"genre_scores_gemma":[0.9775689,0.001696218,0.005025594,0.001614414,0.0002728518,0.004046641,0.006180396,0.00007416001,0.003520765],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002613623,"threshold_uncertainty_score":0.01226526,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1540066286250848,"score_gpt":0.4643010997243615,"score_spread":0.3102944710992767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}